Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 25:15:245.
doi: 10.1186/s12883-015-0494-y.

The economic impact of epilepsy: a systematic review

Affiliations

The economic impact of epilepsy: a systematic review

Katharina Allers et al. BMC Neurol. .

Abstract

Background: In this review we aimed to determine the economic impact of epilepsy and factors associated with costs to individuals and health systems.

Methods: A narrative systematic review of incidence and case series studies with prospective consecutive patient recruitment and economic outcomes published before July 2014 were retrieved from Medline, Embase and PsycInfo.

Results: Of 322 studies reviewed, 22 studies met the inclusion criteria and 14 were from high income country settings. The total costs associated with epilepsy varied significantly in relation to the duration and severity of the condition, response to treatment, and health care setting. Where assessed, 'out of pocket' costs and productivity losses were found to create substantial burden on households which may be offset by health insurance. However, populations covered ostensibly for the upfront costs of care can still bear a significant economic burden.

Conclusions: Epilepsy poses a substantial economic burden for health systems and individuals and their families. There is uncertainty over the degree to which private health insurance or social health insurance coverage provides adequate protection from the costs of epilepsy. Future research is required to examine the role of different models of care and insurance programs in protecting against economic hardship for this condition, particularly in low and middle income settings.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PRISMA Flowchart of included and excluded studies

References

    1. Kotsopoulos IA, Van Merode T, Kessels FG, De Krom MC, Knottnerus JA. Systematic Review and Meta‐analysis of Incidence Studies of Epilepsy and Unprovoked Seizures. Epilepsia. 2002;43(11):1402–1409. doi: 10.1046/j.1528-1157.2002.t01-1-26901.x. - DOI - PubMed
    1. Sander J, Shorvon S. Incidence and prevalence studies in epilepsy and their methodological problems: a review. J Neurol Neurosurg Psychiatry. 1987;50(7):829–839. doi: 10.1136/jnnp.50.7.829. - DOI - PMC - PubMed
    1. Forsgren I, Beghi E, Ekman M. Cost of epilepsy in Europe. Eur J Neurol. 2005;12(s1):54–58. doi: 10.1111/j.1468-1331.2005.01191.x. - DOI - PubMed
    1. Cockerell OC, Hart YM, Sander JW, Shorvon SD. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res. 1994;18(3):249–260. doi: 10.1016/0920-1211(94)90045-0. - DOI - PubMed
    1. Hackett ML, Glozier NS, Martiniuk AL, Jan S, Anderson CS. Sydney epilepsy incidence study to measure illness consequences: the SESIMIC observational epilepsy study protocol. BMC Neurol. 2011;11(1):3. doi: 10.1186/1471-2377-11-3. - DOI - PMC - PubMed

Publication types

Substances